These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2328 related items for PubMed ID: 12668349

  • 21. Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models.
    Kalueff AV, Stewart AM, Song C, Gottesman II.
    Neurosci Biobehav Rev; 2015 Jun; 53():25-36. PubMed ID: 25813308
    [Abstract] [Full Text] [Related]

  • 22. The concept of endophenotypes in psychiatric diseases meeting the expectations?
    Puls I, Gallinat J.
    Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S37-43. PubMed ID: 18756419
    [Abstract] [Full Text] [Related]

  • 23. [Neurophysiological endophenotypes and schizophrenic disorder: emergence and evolution of a clinical concept].
    Micoulaud Franchi JA, Vion Dury J, Cermolacce M.
    Encephale; 2012 Dec; 38 Suppl 3():S103-9. PubMed ID: 23279983
    [Abstract] [Full Text] [Related]

  • 24. [Electrophysiology and schizophrenic vulnerability: the P300 component as endophenotype candidate?].
    Cermolacce M, Micoulaud JA, Naudin J, Vion-Dury J.
    Encephale; 2011 Oct; 37(5):353-60. PubMed ID: 22032278
    [Abstract] [Full Text] [Related]

  • 25. [New strategies in schizophrenia: impact of endophentotypes].
    Opgen-Rhein C, Neuhaus A, Urbanek C, Dettling M.
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S194-9. PubMed ID: 15586310
    [Abstract] [Full Text] [Related]

  • 26. [Endophenotypes in psychiatry: an interim evaluation].
    Zitman FG.
    Ned Tijdschr Geneeskd; 2008 Aug 30; 152(35):1911-3. PubMed ID: 18808079
    [Abstract] [Full Text] [Related]

  • 27. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia.
    Mazhari S, Price G, Dragović M, Waters FA, Clissa P, Jablensky A.
    Brain Cogn; 2011 Nov 30; 77(2):223-30. PubMed ID: 21924537
    [Abstract] [Full Text] [Related]

  • 28. Psychophysiological measures of (dis)inhibition as liability indicators for schizophrenia.
    Clementz BA.
    Psychophysiology; 1998 Nov 30; 35(6):648-68. PubMed ID: 9844427
    [Abstract] [Full Text] [Related]

  • 29. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives.
    Kathmann N, Hochrein A, Uwer R, Bondy B.
    Am J Psychiatry; 2003 Apr 30; 160(4):696-702. PubMed ID: 12668358
    [Abstract] [Full Text] [Related]

  • 30. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?
    Chan RC, Gottesman II.
    Neurosci Biobehav Rev; 2008 Jul 30; 32(5):957-71. PubMed ID: 18462797
    [Abstract] [Full Text] [Related]

  • 31. [Endophenotypes: the molecular biology point of view].
    Belzeaux R, Ibrahim EC, Cermolacce M, Fakra E, Azorin JM.
    Encephale; 2012 Dec 30; 38 Suppl 3():S62-6. PubMed ID: 23279989
    [Abstract] [Full Text] [Related]

  • 32. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research.
    Swerdlow NR, Gur RE, Braff DL.
    Schizophr Res; 2015 Apr 30; 163(1-3):9-16. PubMed ID: 25454799
    [Abstract] [Full Text] [Related]

  • 33. Schizophrenia, VII: defining the neurobiology of risk factors.
    Hong LE, Avila M, Thaker GK.
    Am J Psychiatry; 2003 Nov 30; 160(11):1929. PubMed ID: 14594735
    [No Abstract] [Full Text] [Related]

  • 34. Using endophenotypes to examine molecules related to candidate genes as novel therapeutics: The "endophenotype-associated surrogate endpoint (EASE)" concept.
    Yamasue H.
    Neurosci Res; 2015 Oct 30; 99():1-7. PubMed ID: 26055442
    [Abstract] [Full Text] [Related]

  • 35. Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives.
    Curtis CE, Calkins ME, Grove WM, Feil KJ, Iacono WG.
    Am J Psychiatry; 2001 Jan 30; 158(1):100-6. PubMed ID: 11136640
    [Abstract] [Full Text] [Related]

  • 36. The endophenotype concept in psychiatric genetics.
    Flint J, Munafò MR.
    Psychol Med; 2007 Feb 30; 37(2):163-80. PubMed ID: 16978446
    [Abstract] [Full Text] [Related]

  • 37. Eye tracking in schizophrenia: does the antisaccade task measure anything that the smooth pursuit task does not?
    Zanelli J, Simon H, Rabe-Hesketh S, Walshe M, McDonald C, Murray RM, Maccabe JH.
    Psychiatry Res; 2005 Sep 15; 136(2-3):181-8. PubMed ID: 16111769
    [Abstract] [Full Text] [Related]

  • 38. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder.
    Etain B, Roy I, Henry C, Rousseva A, Schürhoff F, Leboyer M, Bellivier F.
    Bipolar Disord; 2007 Nov 15; 9(7):706-12. PubMed ID: 17988360
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Eye tracking disorders in schizophrenic patients and their parents].
    Boudet C, Denise P, Bocca ML, Chabot B, Abadie P, Brazo P, Benali K, Dollfus S.
    Encephale; 2001 Nov 15; 27(6):551-8. PubMed ID: 11865562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 117.